Ocular myasthenia gravis is one of the mildest types of myasthenia gravis, so it does not normally affect life expectancy, but as the disease progresses, it can develop into other types of myasthenia gravis, which affects the respiratory muscles and can be life-threatening.
Ocular myasthenia gravis is a type of myasthenia gravis, which is characterized by drooping upper eyelids, inflexible eye movements, diplopia, strabismus, etc. It is characterized by “light in the morning and heavy in the evening”, i.e., myasthenia gravis decreases in the morning after waking up or resting, and aggravates in the afternoon or evening after exertion. It is usually treated with drugs such as brompheniramine, glucocorticoids and immunosuppressants.
Patients with oculomotor myasthenia gravis who are well controlled by standardized medication generally do not have life-threatening effects. However, if the disease progresses and develops into other types of myasthenia gravis that involve the respiratory muscles, it can be life-threatening at any time if it is not treated in a timely manner.
After diagnosis of ocular myasthenia gravis, you should actively cooperate with your doctor for treatment.